Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Aethlon Medical to Present the Aethlon ADAPTâ„¢ System at C21 BioVenturesâ„¢ Life Sciences Partnering Conference

May 23, 2011 By Bio-Medicine.Org

SAN DIEGO, May 23, 2011 /PRNewswire/ — Aethlon
Medical, Inc.
(OTC Bulletin Board:
AEMD
), the pioneer in developing therapeutic filtration devices
to address infectious disease and cancer, announces that Chairman
and CEO James A. Joyce will present the Aethlon ADAPT™ system
in a presentation at the C21 BioVentures™ Life Sciences
Partnering Conference on Wednesday, May 26, 2011, at 3:00 p.m.
Pacific time at the Meritage Resort in Napa, Calif.  The newly
introduced Aethlon ADAPT™ system is an adaptive dialysis-like
affinity platform technology that provides a less burdensome
medical device regulatory pathway for therapeutic antibodies and
other affinity drugs agents.

(Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)

“The C21 partnering conference is an ideal venue to introduce
our Aethlon ADPAPT™ system to senior drug industry executives
that are facing increasingly unpredictable regulatory challenges as
well as emerging competition from generics and biosimilars,” said
Mr. Joyce.  “Our platform technology allows marketed drugs,
clinical-stage drugs, and agents that previously failed clinical
studies to be repurposed within a therapeutic filtration design
that results in an expedited and less costly medical device
pathway.”  

The Aethlon ADAPT™ system allows for the selective removal
of disease-related particles from the entire circulatory system
without the loss of essential blood components.  It eliminates
the need to infuse drug agents into the body as blood filtration
occurs ex vivo.  As a result, new devices evolved from
this platform will not add drug toxicity or drug-drug interaction
risks if combined with other therapies.  The Aethlon
ADAPT™ system also provides the potential to

‘/>”/>

SOURCE

Related Articles Read More >

Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial
CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech